Cover Image

Custom Mega Prosthetic Reconstruction of distal femoral malignant giant cell tumor - A case report.

RAGAVANANDAM R

Abstract


Giant cell tumours (GCT) are benign to aggressive lesions which are frequently encountered in orthopaedic  practice. They represent 3-4 of all primary tumors of bone, occurring in young healthy adults in the third and fourth decade of life. The ends of long bones in skeletally mature individuals are involved in more than 80 of cases and 75 of them occur around the knee joint. Eighty per cent of the GCT have a benign course, with a local recurrence rate of 10-50 about 10 of GCT undergo malignant transformation through their recurrences and 1-4 give pulmonary metastases even in case of a benign histology. For last two decades, there is technical advances in surgical management of GCTs with introduction of new techniques and improvising of the existing techniques. There is a universal consensus in favour of  extended curettage with or without adjuvants even in   recurrent cases. Current evidence suggested that curettage alone in cysts of 60 cm3 (about 5 cm in diameter) yielded satisfactory results, and lesions greater than this carry a very high risk of pathological fracture or late development of        osteoarthritis and a filler is essential1. Also lesions in which more than 23rd of the cortex of the bone is destroyed in a single view, prophylactic fixation is adviced2. We consider worthwhile reporting a case of distal femoral aggressive GCT in 28 years old female, treated by wide excision and   reconstruction with custom mega prosthesis with good  functional outcome.

 


Full Text:

PDF

References


Aston W, Briggs T, Solomon L (2010) Tumours. In: Solomon L, Warwick D, Nayagam S (eds) Apley's system ofOrthopaedics and Fractures, 9th edn. Hooder Arnold, London, pp 187-223

Hirn M, de Silva U, Sidharthan S, Grimer RJ, Abudu A, Tillman RM, Carter SR. Bone defects following curettage do not necessarily need augmentation. Acta Orthop 2009; 80(1): 4-8

N atarajan MV, Prabhakar R, Mohamed SM, Shashidhar R. Management of juxta articular giant cell tumors around the knee by custom mega prosthetic arthroplasty. Indian J Orthop 2007;41: 134-8.

Eckardt JJ, Grogan TJ. Giant cell tumor of bone. Clin Orthop Relat Res 1986;204:45-58.

Ghert MA, Rizzo M, Harrelson JM, Scully SP. Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res 2002;400:201-10.

Szendröi M. Giant-cell tumour of bone. J Bone Joint Surg Br 2004;86:5-12.

McGrath PJ. Giant-cell tumour of bone: An analysis of fi fty-two cases. J Bone Joint Surg Br 1972;54:216-29.

Kawai A, Lin PP, Boland PJ, Athanasian EA, Healey JH. Relationship between magnitude of resection, complication, and prosthetic survival after prosthetic knee reconstructions for distal femoral tumors. J Surg Oncol 1999;70:109-15. 80 Medical Journal of Dr. D.Y. Patil University | January- February 2015 | Vol 8 | Issue 1

Hillmann A, Hoffmann C, Gosheger G, Krakau H, Winkelmann W. Malignant tumor of the distal part of the femur or the proximal part of the tibia: Endoprosthetic replacement or rotationplasty. Functional outcome and quality-of-life measurements. J Bone Joint Surg Am 1999;81:462-8.

Natarajan MV, Annamalai K, Williams S, Selvaraj R, Rajagopal TS. Limb salvage in distal tibial osteosarcoma using a custom mega prosthesis. Int Orthop 2000;24:282-4.


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr MGR Medical University